Voloridge Investment Management, LLC Celldex Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

  • $26.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$34.78 - $47.43 $240,538 - $328,025
6,916 New
6,916 $248,000
Q1 2022

May 16, 2022
SELL
$27.64 - $39.32 $3.68 Million - $5.23 Million
-132,993 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$35.68 - $56.27 $1.1 Million - $1.74 Million
30,847 Added 30.2%
132,993 $5.14 Million
Q3 2021

Nov 15, 2021
BUY
$28.95 - $55.99 $2.96 Million - $5.72 Million
102,146 New
102,146 $5.52 Million

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.22B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email